Although the actions of IL-23 in other neuroinflammatory processes like MS are mediated via Th17 cells (19, 20), in AD, IL-23 and IL-12/23 p40 might act through novel mechanisms independent from T cells. This evidence concerns the gene IL37 and myeloid sarcoma.